Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
The Lancet. Respiratory Medicine|March 20, 2018
Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association studyDaniel B Hawcutt, Ben Francis, Daniel F Carr, et al.
The New England Journal of Medicine|November 21, 2013
A randomized trial of genotype-guided dosing of warfarinMunir Pirmohamed, Girvan Burnside, Niclas Eriksson, et al.
Clinical Immunology (Orlando, Fla.)|May 5, 2022
Real world treatment of juvenile-onset systemic lupus erythematosus: Data from the UK JSLE cohort studyEve M D Smith, Naomi Egbivwie, Andrea L Jorgensen, et al.
Rheumatology (Oxford, England)|January 20, 2026
Validating treat-to-target endpoints in childhood lupus: data-driven sensitivity analyses from the UK JSLE cohort studyChandni Sarker, Andrea L Jorgensen, Kukatharmini Tharmaratnam, et al.
Rheumatology (Oxford, England)|February 6, 2025
Validation of childhood lupus specific targets: ensuring accurate assessment of disease control in younger, lighter paediatric patientsChandni Sarker, Andrea L Jorgensen, Kukatharmini Tharmaratnam, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 15, 2021
ADRB2 haplotypes and asthma exacerbations in children and young adults: An individual participant data meta-analysisLeila Karimi, Susanne J Vijverberg, Marjolein Engelkes, et al.
Clinical Pharmacology and Therapeutics|December 24, 2019
Genetic Factors Influencing Warfarin Dose in Black-African Patients: A Systematic Review and Meta-AnalysisInnocent G Asiimwe, Eunice J Zhang, Rostam Osanlou, et al.
Blood Advances|August 20, 2024
Meta-analysis of genome-wide association studies of stable warfarin dose in patients of African ancestryInnocent G Asiimwe, Marc Blockman, Larisa H Cavallari, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 11, 2021
Genome-wide association studies of exacerbations in children using long-acting beta2-agonistsElise M A Slob, Levi B Richards, Susanne J H Vijverberg, et al.
Thrombosis and Haemostasis|December 22, 2011
Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapyBenjamin D Horne, Petra A Lenzini, Mia Wadelius, et al.
Pageof 8